FDA Adverse Event Death Summary report: N

RESOLUTE INTEGRITY RX

MDR report key: 3070008 · Received April 22, 2013

Report

Report Number
9612164-2013-00447
Event Type
Death
Date Received
April 22, 2013
Date of Event
November 11, 2013
Report Date
August 8, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P110013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

EVALUATION RESULTS: INHERENT RISK OF PROCEDURE ¿ (DEATH). EVALUATION CONCLUSIONS: INHERENT RISK OF PROCEDURE ¿ (DEATH). (B)(4).

Additional Manufacturer Narrative · 1

EVALUATION RESULTS AND CONCLUSION: (MYOCARDIAL INFARCTION). (B)(4).

Description of Event or Problem · 1

CLINICAL EVENTS COMMITTEE HAVE ADJUDICATED THAT THE REPORTED MI OCCURRED ONE DAY PRIOR TO THAT PREVIOUSLY REPORTED AND WAS AN ARC MI.

Description of Event or Problem · 1

APPROXIMATELY 7 MONTHS POST INDEX PROCEDURE, PATIENT SUFFERED PNEUMONIA WITH AN OUTCOME OF DEATH.

Description of Event or Problem · 1

DATE OF DEATH IS CONFIRMED AS THE (B)(6) 2013. CEC HAS INDICATED PATIENT DEATH WAS NON-CARDIAC DUE TO PNEUMONIA WITH CAD AND PULMONARY FIBROSIS AS CONTRIBUTING FACTORS.

Description of Event or Problem · 1

DURING INDEX PROCEDURE THE PATIENT HAD TWO RESOLUTE INTEGRITY DRUG-ELUTING STENTS IMPLANTED, ONE IN THE LAD AND ONE IN THE LCX. ONE DAY POST INDEX PROCEDURE, A PERI-PROCEDURAL MI WAS REPORTED WITH A RISE IN CKMB. THE PATIENT RECOVERED WITHOUT TREATMENT. INVESTIGATOR DID NOT INDICATE WHETHER THE REPORTED EVENT WAS RELATED TO THE STUDY DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
172422 RESOLUTE INTEGRITY RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND 0006640043

Patients

Seq Age Sex Outcome Treatment
1 00074 YR Death| H CLOPIDOGREL AND ASPIRIN.